Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HTD1801 in Adults With Hypercholesterolemia
NCT03381287Phase 2Completed
- Sponsor
- HighTide Therapeutics, Inc.
- Start
- Apr 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of berberine ursodeoxycholate in hypercholesterolemia, sponsored by HighTide Therapeutics, Inc.. Started Apr 2018; status: completed.
02
Drugs
berberine ursodeoxycholate
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT03381287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03381287.